Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus

Sultan

Regular Member

Joined : Jan 2006

Posts : 250

Posted 1/13/2023 8:44 PM (GMT 0)

https://www.fiercebiotech.com/biotech/fresh-pfizer-deal-roivant-posts-best-class-ulcerative-colitis-data-and-stokes-prometheus

Sara14

Veteran Member

Joined : Mar 2007

Posts : 7914

Posted 1/13/2023 10:22 PM (GMT 0)

Sounds promising. Wonder why Pfizer gave it up.

Rusty Barr

Regular Member

Joined : Feb 2016

Posts : 456

Posted 1/23/2023 5:03 PM (GMT 0)

Interesting to see this verbiage in the article:

“Roivant Sciences has shown its hand in the red-hot race for a new ulcerative colitis market.”

The good news in what I see here…is that comment …is that pharmaceutical companies “are racing” to come up with drugs for us.

The bad news is, that’s probably because how much money they are making ripping off the insurance companies. The profit markup off the charts.

GrittyHope

Regular Member

Joined : Mar 2022

Posts : 138

Posted 1/23/2023 6:04 PM (GMT 0)

Rusty, I read that in the article and though, "Oof, it doesn't even pretend we're people; it just tells the truth that it's about a 'market.'"

But then I remind myself that while COMPANIES are out to maximize profits, there are beautifully well-intentioned SCIENTISTS seeking to help us. I do really believe this.

✚ New Topic ✚ Reply